Debate continues over the optimal dose of sotorasib. Recent studies show mixed results between 960-mg and 240-mg doses. bit.ly/4bFViPD #NSCLC UChicagoCancerCenter

A new nanomedicine with STING agonist show improved cancer drug delivery. Exciting advancements in the cancer treatment are coming from collaboration between the UChiPhysicalSciences and UChicago Biological Sciences. Wenbin Lin Ralph Weichselbaum UChicago Chemistry Ludwig Cancer ow.ly/5niz50T6pNl

Screening is the best way to catch several types of cancer early. Learn how — and when — your primary care provider (PCP) can help. uchicagomedicine.org/forefront/canc…

The Jonas Center Cellular Therapy Symposium is just around the corner! Join us virtually or in person in Chicago on September 20 by registering at cme.uchicago.edu/JCCTS2024. Learn more here! UChicago Medicine UChicagoCancerCenter

When it comes to cancer, we don’t have time to wait. We have to be impatient for our patients. In the latest Coping with Cancer, I shared my thoughts on the meaningful advances NCI has made since last year, as well as new opportunities to be optimistic about. spr.ly/6018mRRdA

People with advanced #EndometrialCancer now have new FDA-approved treatment options: pembrolizumab and durvalumab, paired with chemotherapy, for tumors with a genetic change called mismatch repair deficiency. go.nih.gov/Qmz5ojG

🎙️Catch up on the latest episodes of our Cancer Luminaries podcast ow.ly/OqOz50SLeHt #NothingWillStopUs #NCIDesignated #UChiCancer50

Congress running out of time to address critical cancer priorities: #drugshortages & federal research funding. Your stories move lawmakers so please tell #ASCOAdvocacy abt treating pts amid shortages or impact of research funding ➡️https://shttps://brnw.ch/21wMaTl #ASCOAdvocacy

Really enjoyed speaking at the ISEH satellite symposium about LSD1 inhibition in myeloid malignancies! Thanks to Caner Saygin, MD & Dr McNerney for the invite!

🎙️Our latest episode of Cancer Luminaries is live. Our alumni star guest is cancer immunologist and alumni star Stefani Spranger from Massachusetts Institute of Technology (MIT) Koch Institute at MIT. podbean.com/eas/pb-qcggn-1…

Join us at Patient and Family Conference for AA, MDS, PNH, co-organized by ⁦UChicago Medicine⁩ and ⁦AA&MDSIF⁩ on Sep 14th.

We showcased our research training programs at our annual Summer Research Symposium. Two special guests — National Cancer Institute Dr. Kimryn Rathmell W. Kimryn Rathmell and U.S. Senate Majority Whip Dick Durbin, D-IL — met with leadership, faculty and students. Watch the video. #UChiCancer50

Today marks an important day for The ConcepcIon Lab UChicagoBMB as we become an NIH NIGMS-funded research Lab. After two years at The University of Chicago, we have assembled a fantastic research team that aims to understand how ion channels regulate immune cell function. (1/6)

I am also thankful for all the support from the UChicagoBMB department, UChicago Committee on Immunology, UChicagoCancerCenter, all my friends and colleagues along the way, and funding agencies: Cancer Research Foundation, American Cancer Society, Institute for Translational Medicine, University of Chicago DDRCC, and The Neubauer Family Foundation. (5/6)

At the University of Chicago, our IrAE Clinical Consortium Team is dedicated to improving care and outcomes for patients with immune-related adverse events. UChicago Medicine The University of Chicago UChicagoCancerCenter University of Chicago Nephrology uchicagomedicine.org/cancer/types-t…

The Raymond Moellering lab have created STR22, a synthetic molecule that blocks hard-to-drug proteins like HIFs and XBP1 to curb tumor growth in triple-negative breast cancer, offering a fresh strategy for hypoxia-driven cancers. Raymond Moellering Nature Chemical Biology nature.com/articles/s4158…

Today, NCI released its FY26 Annual Plan & Professional Judgment Budget Proposal—my first as NCI director. It outlines the funding needed to capitalize on scientific opportunities + advance our goal to #EndCancerAsWeKnowIt. Please read + share! go.nih.gov/8zYJsc9 #NCIFuture

#SOHO24 has us all smiling! Thank you Soni Smith MD for stopping by and sharing your insights on T-cell directed therapy for indolent B-cell lymphoma! #LYMSM #SOHO24 | UChicago Medicine UChicagoCancerCenter University of Chicago Hematology/Oncology Society of Hematologic Oncology (SOHO)

📚 🩸 Calling all residents preparing to apply for a fellowship! The application for the ASH Hematology-Focused Fellowship Training Program (HFFTP) is still open! Learn more about the HFTTP program and all the benefits here: ow.ly/akg150Soyvb #Hematology #MedEd #MedTwitter

September marks #ChildhoodCancerAwarenessMonth 🎗️ Our pediatric cancer specialists are at the forefront of cancer care, offering advanced care through innovative therapies, and latest treatments through clinical trials. Comer Children's Hospital UChicagoCancerCenter ow.ly/rLY850TgtLa